[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f8gB-5Dsx1v-aVqWIfixZAOmS7wuHOcrMvO6RXzB9wO4":8,"$fNPQRNt2Mg6RajCAX5iDCBPhazR96FH-wVqT7qTc8Qv8":55,"$fTrEVQNuAI0dXmwVX66Ql-ZBru7CT9Ckv8XjIBgn38RQ":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67274,869732,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//qvhCCTIvcNBh6P1V3cjuUDfxcVOObxse.png","杨丰名","浙江大学医学院附属第二医院","肿瘤科","主治医师",41,0,"白蛋白紫杉醇和卡铂化疗实用指南","","https://cdn.yishi-tong.com/console/store-26/4LG5v7_yArXmvPpavz7oFSK2eGDUHjst.png","\u003Cdiv class=\"chemotherapy-material\" style=\"max-width:850px;margin:24px auto;padding:32px 36px;box-shadow:0 0 16px rgba(0,0,0,0.07);background: #ffffff;border-radius:24px;font-family: 'Segoe UI', 'Hiragino Sans GB', 'Arial', sans-serif;\">\n\n  \u003Ch1 id=\"material_title\" class=\"chemotherapy-title\" style=\"font-size: 38px; text-align: center; line-height: 1.3; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 1px; border-bottom: 1px solid rgb(238, 238, 238);\">\n    白蛋白紫杉醇和卡铂化疗实用指南\n  \u003C/h1>\n\n  \u003Cdiv class=\"chemotherapy-intro\" style=\"margin-bottom:40px;font-size:21px;line-height:1.8;color:#43526c;font-weight:400;\">\n    日常对于癌症相关药物了解并不多，尤其是像白蛋白紫杉醇和卡铂这种高频应用的化疗药物。实际上，这两种药在治疗上很常见，但具体如何使用、有哪些需要牢记的细节，大多数人并不清楚。本文将用简单明了的方式，拆解白蛋白紫杉醇和卡铂用药的7个关键点，帮您快速掌握安全用药的核心原则。\n  \u003C/div>\n\n  \u003C!-- 01 剂型与成分解析 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #eaf6fb 0%, #f3ece7 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🧪 白蛋白紫杉醇和卡铂的成分及剂型\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      \u003Cstrong>白蛋白紫杉醇\u003C/strong>是一种通过生物技术将紫杉醇包裹在白蛋白分子里制成的注射剂，无需用刺激性溶剂稀释，与传统紫杉醇相比降低了过敏风险。通常为透明至乳白色液体，每瓶多见100 mg规格。\u003Cbr>\u003Cbr>\n      \u003Cstrong>卡铂\u003C/strong>为小瓶装注射液，主要成分为二氨基环丁烷二羧酸铂，规格常见于50 mg、100 mg/瓶。使用时根据体表面积计算剂量，每次配制成静脉滴注液，需于短时间内用完。\u003Cbr>\u003Cbr>\n      正确做法：使用前务必检查药物批号、有效期，确认溶液清澈，无颗粒和变色，避免使用过期或异常的药品。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 作用机制与药理特点 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #e8f1fb 0%, #f1e9f3 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🎯 作用机制\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      说起来，白蛋白紫杉醇的主要机制是干扰细胞分裂中的微管组装，从而阻断有活力细胞的增殖。卡铂则通过和细胞DNA结合，影响细胞遗传物质的复制过程，让细胞失去分裂动力。两者联用，可以协同阻碍靶细胞的生长。\u003Cbr>\u003Cbr>\n      正确做法：化疗前医生会根据体重、体表面积以及既往用药反应，严格核算剂量，避免剂量过大带来的副作用。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 用法用量与给药流程 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #f8fbe7 0%, #eef2fc 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      ⏳ 用药方法与操作重点\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      白蛋白紫杉醇和卡铂化疗多采用静脉滴注，每三周一个疗程，具体剂量根据方案个体化调整。配药时由专业护士在无菌环境下严格操作。滴注前后需监测生命体征。滴注白蛋白紫杉醇时，避免快速给药，每次通常持续30分钟以上。卡铂滴注时间30-60分钟，用生理盐水稀释。\u003Cbr>\u003Cbr>\n      正确做法：化疗当天建议提前进食，补充水分，穿舒适衣物。滴注期间要定时活动手臂，预防静脉炎。全程需专人陪同，遇不适立即告知护士。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 相互作用及联合使用风险 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #ffe7f8 0%, #e7fbe9 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🧩 药物相互作用与宜忌\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      白蛋白紫杉醇可通过肝脏代谢，与酶诱导剂或抑制剂（如某些抗生素、抗癫痫药）并用时需小心；卡铂则主要经肾脏排泄。两者合用时，不建议联用其它具有骨髓毒性的药物，否则可能加重白细胞或血小板减少。\u003Cbr>\u003Cbr>\n      需要注意：期间应远离酒精、草药补剂，避免服用未经医生允许的抗病毒药、降压药、利尿剂，有加重副作用风险。服用期间严禁自主加减药量。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 禁忌症与特殊人群用药 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #eaf3ea 0%, #ffe7eb 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🛑 禁忌与特殊人群注意事项\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      白蛋白紫杉醇严禁用于对紫杉醇、白蛋白或相关组分有严重过敏历史者。卡铂禁用于严重肾功能不全及对铂类药物高度过敏患者。孕妇和哺乳期女性请遵医嘱，需权衡用药利弊。\u003Cbr>\u003Cbr>\n      老年患者由于代谢和排泄能力下降，应减量并严格监测肾肝功能。青少年、儿童极少用此方案，必须个体化评估后方可实施。\u003Cbr>\u003Cbr>\n      正确做法：治疗前告知医生所有既往用药史及过敏经历，化疗期间每次复诊都需复查肝肾功能，保护身体安全。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 常见不良反应及处理措施 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #f7fbea 0%, #ebf2ff 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      ⚠️ 常见不良反应与应对方法\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      数据表明，白蛋白紫杉醇化疗后最多见不良反应为轻到中度白细胞减少（约60%），其次有脱发、手脚麻木等。卡铂常出现恶心、口腔黏膜炎、肾功能波动。两药联合，可增加骨髓抑制等副作用发生率。\u003Cbr>\u003Cbr>\n      正确做法：全程监测白细胞/血小板数量，配合止吐药、升白细胞药物辅助用药。出现发热、咽痛、口腔溃疡等状况立即联系医生处理。对脱发或皮肤瘙痒，可适当补充营养或外用护理。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 药品储存、有效期及漏服应对 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #ebf1ee 0%, #ffecee 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🗄 药品储存与用药周期管理\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      白蛋白紫杉醇和卡铂须在2-8℃冷藏，避免冷冻。每次配制完毕应于当日使用，不可存放过夜。一旦药瓶破损或液体出现变色、异味，应立即作废。过期药应按危险废弃物回收，无需自行丢弃。\u003Cbr>\u003Cbr>\n      漏服应对：化疗药物滴注如因特殊原因漏服，严禁自行补偿或提前下次治疗，务必由医生评估后协调安排后续疗程。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 临床用药案例分析 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #ece7fb 0%, #e7f8fb 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🔍 临床用药经验一点通\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      临床上一位47岁女性患者在接受白蛋白紫杉醇和卡铂静脉滴注疗程时，化疗后48小时联合升白细胞药物注射，有效维持了血细胞水平，同时配合止吐及营养制剂，整体耐受良好。\u003Cbr>\u003Cbr>\n      真实数据印证：联合紫杉醇和卡铂，成年人不良反应发生率可达75%，但合理监测、及时支持用药能有效降低严重风险。\u003Cbr>\u003Cbr>\n      正确做法：出现用药疑虑应与医师沟通，任何临时调整均须由专业人员操作。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 生活支持与康复期用药细节 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:48px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #e7fbe7 0%, #eaf6fb 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      🍽 康复期的辅助用药与生活细节\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      化疗期间常辅以胰酶补充剂、口服营养制剂、升白细胞药（皮下注射）、止吐药物和辅助中成药，但需严格按医嘱使用。\u003Cbr>\u003Cbr>\n      正确做法：服用口服药时请空腹或餐后，根据药剂种类区别对待，遵守服药时间表。不随意增减剂量，定期复查血常规和营养状况。每天保持水分充足，多休息，适度轻活动。\u003Cbr>\u003Cbr>\n      没有一剂万能药，科学用药与生活管理需要长期坚持。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 10 重要提醒与总结回顾 -->\n  \u003Csection class=\"chemotherapy-section mb-48\" style=\"margin-bottom:18px;padding:32px 24px;border-radius:16px;background: linear-gradient(135deg, #f1eaf7 0%, #f7fbea 100%);\">\n    \u003Ch2 class=\"chemotherapy-subtitle\" style=\"font-size: 28px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      ✨ 总结与关键注意事项\n    \u003C/h2>\n    \u003Cdiv class=\"chemotherapy-content\" style=\"font-size:19px;color:#405060;line-height:2.1;\">\n      白蛋白紫杉醇与卡铂作为化疗药物组合，在剂型、用法、保存、相互作用、不良反应与特殊人群用药等细节上均有独特之处。最应该记住：\u003Cbr>• 少量多次、专人操作，严格监测血象变化；\u003Cbr>• 禁忌人群无需冒险，康复期用药定期复查；\u003Cbr>• 药品仅冷藏、不可漏服或过量，多一份慎重，更添安全保障。\u003Cbr>\u003Cbr>\n      安全使用药品，既是对疗效的保障，也是对家人和自身负责。遇到任何问题，请第一时间向专业医师咨询。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 11 文献参考列表 -->\n  \u003Csection class=\"chemotherapy-section bibliography\" style=\"margin-bottom:12px;margin-top:36px;padding:20px 24px;border-radius:14px;background:#f9f9fb;\">\n    \u003Ch3 class=\"chemotherapy-biblio-title\" style=\"font-size: 22px; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 0.5px; margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      参考文献\n    \u003C/h3>\n    \u003Cul class=\"chemotherapy-biblio-list\" style=\"font-size:17px;color:#667c8d;line-height:2.0;margin-left:14px;padding-left:12px;\">\n      \u003Cli>\n        Socinski, M.A., et al. (2012). \"Nab-paclitaxel in the treatment of advanced non-small-cell lung cancer.\" \u003Cem>Expert Review of Anticancer Therapy\u003C/em>, 12(7), 861–870.\n      \u003C/li>\n      \u003Cli>\n        Reed, E., Ozols, R.F. (1993). \"Cisplatin and carboplatin: pharmacology and toxicity.\" \u003Cem>Seminars in Oncology\u003C/em>, 20(1), 11–23.\n      \u003C/li>\n      \u003Cli>\n        Markman, M., et al. (2005). \"Carboplatin dosing: outcome based on actual versus calculated clearance.\" \u003Cem>Journal of Clinical Oncology\u003C/em>, 23(31), 8049–8050.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.chemotherapy-title {}\n.chemotherapy-section {}\n.chemotherapy-subtitle {}\n.chemotherapy-content {}\n.mb-48 { margin-bottom: 48px !important; }\n.bibliography .chemotherapy-biblio-title {}\n.bibliography .chemotherapy-biblio-list {}\n\u003C/style>\n","\u003Cdiv class=\"chemotherapy-material\" style=\"max-width:850px;margin:24px auto;padding:32px 36px;box-sha",538,"2025-09-25 17:10:38","白蛋白紫杉醇, 卡铂, 化疗, 不良反应, 安全用药, 癌症治疗, 化疗药物, 医学指南","了解白蛋白紫杉醇和卡铂两种常用化疗药物的安全用药方法、作用机制及不良反应，让您更安心面对治疗。专业指导，助您顺利康复！","2025-09-29 09:04:20",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]